
Antonio Hardan
Director, Autism and Developmental Disabilities Clinic · Stanford Health Care
Credentials: · · · · ·
History
- Present
Outpatient Program · Stanford Health Care
- Present
- Present
Division of Child and Adolescent Psychiatry and Child Development · Stanford Health Care
- 1993–1996
- 1991–1993
Strong Memorial Hospital (1993) NY
- 1988–1991
St Elizabeth Hospital (1991) DC
- 1984–1988
Doctor of Medicine
Research
Journal of the American Academy of Child & Adolescent Psychiatry · 2014 · Last of 4 authors · 273 citations
Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism
Proceedings of the National Academy of Sciences of the United States of America · 2017 · Last of 13 authors · 265 citations
Brain anatomy and development in autism: review of structural MRI studies
Review · Brain Research Bulletin · 2003 · 248 citations

29 papers
- CE
25 papers
- NM
25 papers

19 papers
- MS
18 papers

12 papers · 6 as a resident

12 papers

11 papers
Grants
- 2026–2031
A Multimodal Assessment Protocol for Characterizing Restricted and Repetitive Behaviors in Autism
National Institute of Mental Health · R01
Contact PI · $767K · Stanford University
- 2014–2030
Developmental Synaptopathies Associated with TSC, PTEN, SHANK3 and SynGAP1 Pathogenic Variants
National Institute of Neurological Disorders and Stroke · U54
Project lead · $707.3K · Boston Children's Hospital
- 2026–2030
Food and Drug Administration · R01
Contact PI · $648K · Stanford University
- 2022–2027
Center for Sleep in Autism Spectrum Disorder
National Institute of Child Health and Human Development · P50
Project lead · $1.9M · Stanford University
Clinical trials
- 2027–2030
Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism
Principal investigator · Not yet recruiting · Phase 2
Stanford University
- 2027–2037
Principal investigator · Not yet recruiting
Stanford University
- 2024–2028
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
Principal investigator · Recruiting
Stanford University
- 2024–2028
Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations
Principal investigator · Withdrawn · Phase 1, Phase 2
Stanford University

